Industry will see more unannounced inspe
In an Interview to CNBCTV18 during visit to India, USFDA Commissioner touched on different topics
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
